Actemra — Blue Cross Blue Shield of Alabama

Initial criteria

• If Actemra is requested for systemic sclerosis associated interstitial lung disease, request must be for Actemra syringe (Actemra ACTpen not approvable for SSc-ILD)

Approval duration

12 months